STAT6 controls the number of regulatory T cells in vivo, thereby regulating allergic lung inflammation

Journal of Immunology

Volumn 191, Issue 4, 2013, Pages 1517-1528

  Dorsey, Nicolas J ^a   Chapoval, Svetlana P ^a   Smith, Elizabeth P ^a   Skupsky, Jonathan ^b   Scott, David W ^c   Keegan, Achsah D ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Uniformed Services University of the Health Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2 RECEPTOR ALPHA; STAT6 PROTEIN;

ADOPTIVE TRANSFER; AIRWAY REMODELING; ALLERGIC LUNG INFLAMMATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTHMA; CONTROLLED STUDY; EOSINOPHIL; IMMUNOMODULATION; IN VIVO STUDY; LUNG LAVAGE; LYMPHOCYTE DEPLETION; LYMPHOCYTE MIGRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; TH2 CELL;

ADMINISTRATION, INTRANASAL; ADOPTIVE TRANSFER; AIRWAY REMODELING; ALLERGENS; ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; DNA-BINDING PROTEINS; FORKHEAD TRANSCRIPTION FACTORS; IMMUNE TOLERANCE; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; INTERLEUKIN-5; LUNG; LYMPHOCYTE COUNT; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; MICE, TRANSGENIC; OVALBUMIN; PULMONARY EOSINOPHILIA; STAT6 TRANSCRIPTION FACTOR; T-LYMPHOCYTES, REGULATORY; TH2 CELLS;

EID: 84881403233     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1300486     Document Type: Article

References (77)

1. Locksley, R. M. 2010. Asthma and allergic inflammation. Cell 140: 777-783.
2. Perkins, C., M. Wills-Karp, and F. D. Finkelman. 2006. IL-4 induces IL-13- independent allergic airway inflammation. J. Allergy Clin. Immunol. 118: 410-419.
3. Robinson, D. S., Q. Hamid, S. Ying, A. Tsicopoulos, J. Barkans, A. M. Bentley, C. Corrigan, S. R. Durham, and A. B. Kay. 1992. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N. Engl. J. Med. 326: 298-304.
4. Wills-Karp, M. 1999. Immunologic basis of antigen-induced airway hyperresponsiveness. Annu. Rev. Immunol. 17: 255-281.
5. Cohn, L., R. J. Homer, A. Marinov, J. Rankin, and K. Bottomly. 1997. Induction of airway mucus production By T helper 2 (Th2) cells: a critical role for interleukin 4 in cell recruitment but not mucus production. J. Exp. Med. 186: 1737-1747.
6. Grünig, G., M. Warnock, A. E. Wakil, R. Venkayya, F. Brombacher, D. M. Rennick, D. Sheppard, M. Mohrs, D. D. Donaldson, R. M. Locksley, and D. B. Corry. 1998. Requirement for IL-13 independently of IL-4 in experimental asthma. Science 282: 2261-2263.
7. Poston, R. N., P. Chanez, J. Y. Lacoste, T. Litchfield, T. H. Lee, and J. Bousquet. 1992. Immunohistochemical characterization of the cellular infiltration in asthmatic bronchi. Am. Rev. Respir. Dis. 145: 918-921.
8. Walker, C., M. K. Kaegi, P. Braun, and K. Blaser. 1991. Activated T cells and eosinophilia in bronchoalveolar lavages from subjects with asthma correlated with disease severity. J. Allergy Clin. Immunol. 88: 935-942.
9. Wills-Karp, M., J. Luyimbazi, X. Xu, B. Schofield, T. Y. Neben, C. L. Karp, and D. D. Donaldson. 1998. Interleukin-13: central mediator of allergic asthma. Science 282: 2258-2261.
10. Kaplan, M. H., U. Schindler, S. T. Smiley, and M. J. Grusby. 1996. Stat6 is required for mediating responses to IL-4 and for development of Th2 cells. Immunity 4: 313-319.
11. Kelly-Welch, A. E., M. E. Melo, E. Smith, A. Q. Ford, C. Haudenschild, N. Noben-Trauth, and A. D. Keegan. 2004. Complex role of the IL-4 receptor alpha in a murine model of airway inflammation: expression of the IL-4 receptor alpha on nonlymphoid cells of bone marrow origin contributes to severity of inflammation. J. Immunol. 172: 4545-4555.
12. Nelms, K., A. D. Keegan, J. Zamorano, J. J. Ryan, and W. E. Paul. 1999. The IL- 4 receptor: signaling mechanisms and biologic functions. Annu. Rev. Immunol. 17: 701-738.
13. Shimoda, K., J. van Deursen, M. Y. Sangster, S. R. Sarawar, R. T. Carson, R. A. Tripp, C. Chu, F. W. Quelle, T. Nosaka, D. A. Vignali, et al. 1996. Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene. Nature 380: 630-633.
14. Lloyd, C. M., and C. M. Hawrylowicz. 2009. Regulatory T cells in asthma. Immunity 31: 438-449.
15. Wei, J., O. Duramad, O. A. Perng, S. L. Reiner, Y. J. Liu, and F. X. Qin. 2007. Antagonistic nature of T helper 1/2 developmental programs in opposing peripheral induction of Foxp3+ regulatory T cells. Proc. Natl. Acad. Sci. USA 104: 18169-18174.
16. Hadeiba, H., and R. M. Locksley. 2003. Lung CD25 CD4 regulatory T cells suppress type 2 immune responses but not bronchial hyperreactivity. J. Immunol. 170: 5502-5510.
17. Lewkowich, I. P., N. S. Herman, K. W. Schleifer, M. P. Dance, B. L. Chen, K. M. Dienger, A. A. Sproles, J. S. Shah, J. Köhl, Y. Belkaid, and M. Wills-Karp. 2005. CD4+CD25+ T cells protect against experimentally induced asthma and alter pulmonary dendritic cell phenotype and function. J. Exp. Med. 202: 1549-1561.
18. Chatila, T. A., F. Blaeser, N. Ho, H. M. Lederman, C. Voulgaropoulos, C. Helms, and A. M. Bowcock. 2000. JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome. J. Clin. Invest. 106: R75-R81.
19. Fontenot, J. D., J. P. Rasmussen, L. M. Williams, J. L. Dooley, A. G. Farr, and A. Y. Rudensky. 2005. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 22: 329-341.
20. Kim, J. M., J. P. Rasmussen, and A. Y. Rudensky. 2007. Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nat. Immunol. 8: 191-197.
21. Kim, J. M., and A. Rudensky. 2006. The role of the transcription factor Foxp3 in the development of regulatory T cells. Immunol. Rev. 212: 86-98.
22. Bluestone, J. A., and A. K. Abbas. 2003. Natural versus adaptive regulatory T cells. Nat. Rev. Immunol. 3: 253-257.
23. Curotto de Lafaille, M. A., and J. J. Lafaille. 2009. Natural and adaptive foxp3+ regulatory T cells: more of the same or a division of labor? Immunity 30: 626-635.
24. Hsieh, C. S., Y. Zheng, Y. Liang, J. D. Fontenot, and A. Y. Rudensky. 2006. An intersection between the self-reactive regulatory and nonregulatory T cell receptor repertoires. Nat. Immunol. 7: 401-410.
25. Chen, W., W. Jin, N. Hardegen, K. J. Lei, L. Li, N. Marinos, G. McGrady, and S. M. Wahl. 2003. Conversion of peripheral CD4+CD252 naive T cells to CD4 +CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J. Exp. Med. 198: 1875-1886.
26. Mucida, D., N. Kutchukhidze, A. Erazo, M. Russo, J. J. Lafaille, and M. A. Curotto de Lafaille. 2005. Oral tolerance in the absence of naturally occurring Tregs. J. Clin. Invest. 115: 1923-1933.
27. Akbari, O., G. J. Freeman, E. H. Meyer, E. A. Greenfield, T. T. Chang, A. H. Sharpe, G. Berry, R. H. DeKruyff, and D. T. Umetsu. 2002. Antigenspecific regulatory T cells develop via the ICOS-ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity. Nat. Med. 8: 1024-1032.
28. Jaffar, Z., T. Sivakuru, and K. Roberts. 2004. CD4+CD25+ T cells regulate airway eosinophilic inflammation by modulating the Th2 cell phenotype. J. Immunol. 172: 3842-3849.
29. Xu, W., Q. Lan, M. Chen, H. Chen, N. Zhu, X. Zhou, J. Wang, H. Fan, C. S. Yan, J. L. Kuang, et al. 2012. Adoptive transfer of induced-Treg cells effectively attenuates murine airway allergic inflammation. PLoS ONE 7: e40314.
30. Pillemer, B. B., Z. Qi, B. Melgert, T. B. Oriss, P. Ray, and A. Ray. 2009. STAT6 activation confers upon T helper cells resistance to suppression by regulatory T cells. J. Immunol. 183: 155-163.
31. Pace, L., S. Rizzo, C. Palombi, F. Brombacher, and G. Doria. 2006. Cutting edge: IL-4-induced protection of CD4+CD252 Th cells from CD4+CD25+ regulatory T cell-mediated suppression. J. Immunol. 176: 3900-3904.
32. Dardalhon, V., A. Awasthi, H. Kwon, G. Galileos, W. Gao, R. A. Sobel, M. Mitsdoerffer, T. B. Strom, W. Elyaman, I. C. Ho, et al. 2008. IL-4 inhibits TGF-beta-induced Foxp3+ T cells and, together with TGF-beta, generates IL-9+ IL-10+ Foxp3(2) effector T cells. Nat. Immunol. 9: 1347-1355.
33. Takaki, H., K. Ichiyama, K. Koga, T. Chinen, G. Takaesu, Y. Sugiyama, S. Kato, A. Yoshimura, and T. Kobayashi. 2008. STAT6 Inhibits TGF-beta1-mediated Foxp3 induction through direct binding to the Foxp3 promoter, which is reverted by retinoic acid receptor. J. Biol. Chem. 283: 14955-14962.
34. Chapoval, S. P., P. Dasgupta, E. P. Smith, L. J. DeTolla, M. M. Lipsky, A. E. Kelly-Welch, and A. D. Keegan. 2011. STAT6 expression in multiple cell types mediates the cooperative development of allergic airway disease. J. Immunol. 186: 2571-2583.
35. Kuperman, D., B. Schofield, M. Wills-Karp, and M. J. Grusby. 1998. Signal transducer and activator of transcription factor 6 (Stat6)-deficient mice are protected from antigen-induced airway hyperresponsiveness and mucus production. J. Exp. Med. 187: 939-948.
36. Tomkinson, A., A. Kanehiro, N. Rabinovitch, A. Joetham, G. Cieslewicz, and E. W. Gelfand. 1999. The failure of STAT6-deficient mice to develop airway eosinophilia and airway hyperresponsiveness is overcome by interleukin-5. Am. J. Respir. Crit. Care Med. 160: 1283-1291.
37. Hoshino, A., T. Tsuji, J. Matsuzaki, T. Jinushi, S. Ashino, T. Teramura, K. Chamoto, Y. Tanaka, Y. Asakura, T. Sakurai, et al. 2004. STAT6-mediated signaling in Th2-dependent allergic asthma: critical role for the development of eosinophilia, airway hyper-responsiveness and mucus hypersecretion, distinct from its role in Th2 differentiation. Int. Immunol. 16: 1497-1505.
38. Mathew, A., J. A. MacLean, E. DeHaan, A. M. Tager, F. H. Green, and A. D. Luster. 2001. Signal transducer and activator of transcription 6 controls chemokine production and T helper cell type 2 cell trafficking in allergic pulmonary inflammation. J. Exp. Med. 193: 1087-1096.
39. Dasgupta, P., S. P. Chapoval, E. P. Smith, and A. D. Keegan. 2011. Transfer of in vivo primed transgenic T cells supports allergic lung inflammation and FIZZ1 and Ym1 production in an IL-4Rα and STAT6 dependent manner. BMC Immunol. 12: 60.
40. Yang, L., L. Cohn, D. H. Zhang, R. Homer, A. Ray, and P. Ray. 1998. Essential role of nuclear factor kappaB in the induction of eosinophilia in allergic airway inflammation. J. Exp. Med. 188: 1739-1750.
41. Skupsky, J., A. H. Zhang, Y. Su, and D. W. Scott. 2010. B-cell-delivered gene therapy induces functional T regulatory cells and leads to a loss of antigenspecific effector cells. Mol. Ther. 18: 1527-1535.
42. Chapoval, S. P., G. H. Nabozny, E. V. Marietta, E. L. Raymond, C. J. Krco, A. G. Andrews, and C. S. David. 1999. Short ragweed allergen induces eosinophilic lung disease in HLA-DQ transgenic mice. J. Clin. Invest. 103: 1707-1717.
43. Burchell, J. T., M. E. Wikstrom, P. A. Stumbles, P. D. Sly, and D. J. Turner. 2009. Attenuation of allergen-induced airway hyperresponsiveness is mediated by airway regulatory T cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 296: L307- L319.
44. Webster, K. E., S. Walters, R. E. Kohler, T. Mrkvan, O. Boyman, C. D. Surh, S. T. Grey, and J. Sprent. 2009. In vivo expansion of T reg cells with IL-2-mAb complexes: induction of resistance to EAE and long-term acceptance of islet allografts without immunosuppression. J. Exp. Med. 206: 751-760.
45. Boyman, O., M. Kovar, M. P. Rubinstein, C. D. Surh, and J. Sprent. 2006. Selective stimulation of T cell subsets with antibody-cytokine immune complexes. Science 311: 1924-1927.
46. Leech, M. D., R. A. Benson, A. De Vries, P. M. Fitch, and S. E. Howie. 2007. Resolution of Der p1-induced allergic airway inflammation is dependent on CD4 +CD25+Foxp3+ regulatory cells. J. Immunol. 179: 7050-7058.
47. Rangan, G. K., and G. H. Tesch. 2007. Quantification of renal pathology by image analysis. Nephrology (Carlton) 12: 553-558.
48. Henderson, W. R., Jr., L. O. Tang, S. J. Chu, S. M. Tsao, G. K. Chiang, F. Jones, M. Jonas, C. Pae, H. Wang, and E. Y. Chi. 2002. A role for cysteinyl leukotrienes in airway remodeling in a mouse asthma model. Am. J. Respir. Crit. Care Med. 165: 108-116.
49. McHugh, R. S., and E. M. Shevach. 2002. Cutting edge: depletion of CD4 +CD25+ regulatory T cells is necessary, but not sufficient, for induction of organ-specific autoimmune disease. J. Immunol. 168: 5979-5983.
50. Stephens, L. A., and S. M. Anderton. 2006. Comment on "Cutting edge: anti-CD25 monoclonal antibody injection results in the functional inactivation, not depletion, of CD4+CD25+ T regulatory cells". J. Immunol. 177: 2036-, author reply 2037-2038.
51. Faustino, L., D. M. da Fonseca, M. C. Takenaka, L. Mirotti, E. B. Florsheim, M. G. Guereschi, J. S. Silva, A. S. Basso, and M. Russo. 2013. Regulatory T cells migrate to airways via CCR4 and attenuate the severity of airway allergic inflammation. J. Immunol. 190: 2614-2621.
52. Elias, J. A., Z. Zhu, G. Chupp, and R. J. Homer. 1999. Airway remodeling in asthma. J. Clin. Invest. 104: 1001-1006.
53. Vignola, A. M., F. Mirabella, G. Costanzo, R. Di Giorgi, M. Gjomarkaj, V. Bellia, and G. Bonsignore. 2003. Airway remodeling in asthma. Chest 123(3, Suppl)417S-422S.
54. Halwani, R., S. Al-Muhsen, and Q. Hamid. 2010. Airway remodeling in asthma. Curr. Opin. Pharmacol. 10: 236-245.
55. Davidson, T. S., and E. M. Shevach. 2011. Polyclonal Treg cells modulate T effector cell trafficking. Eur. J. Immunol. 41: 2862-2870.
56. Maganto-García, E., D. X. Bu, M. L. Tarrio, P. Alcaide, G. Newton, G. K. Griffin, K. J. Croce, F. W. Luscinskas, A. H. Lichtman, and N. Grabie. 2011. Foxp3+-inducible regulatory T cells suppress endothelial activation and leukocyte recruitment. J. Immunol. 187: 3521-3529.
57. Coffer, P. J., R. C. Schweizer, G. R. Dubois, T. Maikoe, J. W. Lammers, and L. Koenderman. 1998. Analysis of signal transduction pathways in human eosinophils activated by chemoattractants and the T-helper 2-derived cytokines interleukin-4 and interleukin-5. Blood 91: 2547-2557.
58. Shi, H., S. Qin, G. Huang, Y. Chen, C. Xiao, H. Xu, G. Liang, Z. Xie, X. Qin, J. Wu, et al. 1997. Infiltration of eosinophils into the asthmatic airways caused by interleukin 5. Am. J. Respir. Cell Mol. Biol. 16: 220-224.
59. Collins, P. D., S. Marleau, D. A. Griffiths-Johnson, P. J. Jose, and T. J. Williams. 1995. Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo. J. Exp. Med. 182: 1169-1174.
60. Akdis, M., and C. A. Akdis. 2009. Therapeutic manipulation of immune tolerance in allergic disease. Nat. Rev. Drug Discov. 8: 645-660.
61. Robinson, D. S., M. Larché, and S. R. Durham. 2004. Tregs and allergic disease. J. Clin. Invest. 114: 1389-1397.
62. Strickland, D. H., P. A. Stumbles, G. R. Zosky, L. S. Subrata, J. A. Thomas, D. J. Turner, P. D. Sly, and P. G. Holt. 2006. Reversal of airway hyperresponsiveness by induction of airway mucosal CD4+CD25+ regulatory T cells. J. Exp. Med. 203: 2649-2660.
63. Umetsu, D. T., O. Akbari, and R. H. Dekruyff. 2003. Regulatory T cells control the development of allergic disease and asthma. J. Allergy Clin. Immunol. 112: 480-487, quiz 488.
64. Saito, K., M. Torii, N. Ma, T. Tsuchiya, L. Wang, T. Hori, D. Nagakubo, N. Nitta, S. Kanegasaki, K. Hieshima, et al. 2008. Differential regulatory function of resting and preactivated allergen-specific CD4+ CD25+ regulatory T cells in Th2-type airway inflammation. J. Immunol. 181: 6889-6897.
65. Setiady, Y. Y., J. A. Coccia, and P. U. Park. 2010. In vivo depletion of CD4 +FOXP3+ Treg cells by the PC61 anti-CD25 monoclonal antibody is mediated by FcgammaRIII+ phagocytes. Eur. J. Immunol. 40: 780-786.
66. Kohm, A. P., J. S. McMahon, J. R. Podojil, W. S. Begolka, M. DeGutes, D. J. Kasprowicz, S. F. Ziegler, and S. D. Miller. 2006. Cutting edge: Anti-CD25 monoclonal antibody injection results in the functional inactivation, not depletion, of CD4+CD25+ T regulatory cells. J. Immunol. 176: 3301-3305.
67. Couper, K. N., D. G. Blount, J. B. de Souza, I. Suffia, Y. Belkaid, and E. M. Riley. 2007. Incomplete depletion and rapid regeneration of Foxp3+ regulatory T cells following anti-CD25 treatment in malaria-infected mice. J. Immunol. 178: 4136-4146.
68. Kulhankova, K., T. Rouse, M. E. Nasr, and E. H. Field. 2012. Dendritic cells control CD4+CD25+ Treg cell suppressor function in vitro through juxtacrine delivery of IL-2. PLoS ONE 7: e43609.
69. Thornton, A. M., E. E. Donovan, C. A. Piccirillo, and E. M. Shevach. 2004. Cutting edge: IL-2 is critically required for the in vitro activation of CD4+CD25+ T cell suppressor function. J. Immunol. 172: 6519-6523.
70. Sarween, N., A. Chodos, C. Raykundalia, M. Khan, A. K. Abbas, and L. S. Walker. 2004. CD4+CD25+ cells controlling a pathogenic CD4 response inhibit cytokine differentiation, CXCR-3 expression, and tissue invasion. J. Immunol. 173: 2942-2951.
71. Battaglia, M., A. Stabilini, E. Draghici, B. Migliavacca, S. Gregori, E. Bonifacio, and M. G. Roncarolo. 2006. Induction of tolerance in type 1 diabetes via both CD4 +CD25+ T regulatory cells and T regulatory type 1 cells. Diabetes 55: 1571-1580.
72. Pandiyan, P., and M. J. Lenardo. 2008. The control of CD4+CD25+Foxp3+ regulatory T cell survival. Biol. Direct 3: 6.
73. Curotto de Lafaille, M. A., N. Kutchukhidze, S. Shen, Y. Ding, H. Yee, and J. J. Lafaille. 2008. Adaptive Foxp3+ regulatory T cell-dependent and -independent control of allergic inflammation. Immunity 29: 114-126.
74. Josefowicz, S. Z., R. E. Niec, H. Y. Kim, P. Treuting, T. Chinen, Y. Zheng, D. T. Umetsu, and A. Y. Rudensky. 2012. Extrathymically generated regulatory T cells control mucosal TH2 inflammation. Nature 482: 395-399.
75. Borish, L., A. Aarons, J. Rumbyrt, P. Cvietusa, J. Negri, and S. Wenzel. 1996. Interleukin-10 regulation in normal subjects and patients with asthma. J. Allergy Clin. Immunol. 97: 1288-1296.
76. Lim, S., E. Crawley, P. Woo, and P. J. Barnes. 1998. Haplotype associated with low interleukin-10 production in patients with severe asthma. Lancet 352: 113.
77. Akdis, M., J. Verhagen, A. Taylor, F. Karamloo, C. Karagiannidis, R. Crameri, S. Thunberg, G. Deniz, R. Valenta, H. Fiebig, et al. 2004. Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells. J. Exp. Med. 199: 1567-1575.